RGNX Competitors & Alternatives
Compare Regenxbio Inc with similar stocks in the same industry
Biotechnology
RGNX
Main Stock$7.03
Tradestie Score
55
Market Cap
$493.52M
Revenue Growth
-0.9%
Analyst Upside
+238.8%
Top Competitors
221 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
DRTS
Alpha Tau Medical Ltd. Ordinary Shares
|
$9.54
|
$371.64M | - | 53 | Compare |
|
CAPR
Capricor Therapeutics Inc
|
$26.61
|
$357.51M | - | 56 | Compare |
|
CGEM
Cullinan Therapeutics, Inc. Common Stock
|
$13.77
|
$354.45M | - | 50 | Compare |
|
LBRX
LB Pharmaceuticals Inc Common Stock
|
$28.32
|
$353.70M | - | 56 | Compare |
|
PROK
ProKidney Corp. Class A Ordinary Shares
|
$1.65
|
$350.98M | - | 53 | Compare |
|
ALT
Altimmune, Inc. Common Stock
|
$2.60
|
$341.56M | - | 55 | Compare |
|
ANNX
Annexon, Inc. Common Stock
|
$4.53
|
$332.96M | - | 47 | Compare |
|
REPL
Replimune Group, Inc.
|
$8.89
|
$328.62M | - | 61 | Compare |
|
CADL
Candel Therapeutics, Inc. Common Stock
|
$8.52
|
$304.12M | - | 58 | Compare |
|
JBIO
Jade Biosciences, Inc. Common Stock
|
$15.87
|
$297.23M | - | 49 | Compare |
More RGNX Analysis
Data updated: Jun 15, 2026 | Industry: Biotechnology (SIC 2836)
221 stocks in this industry